Sunshine Biopharma Inc. (SBFM) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-28 | 8-K | Officer / Director Changes | SEC |
| 2026-08-03 | 8-K | Other Events | SEC |
| 2026-07-20 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-07-10 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-29 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-19 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-20 | 8-K | Shareholder Vote Results | SEC |
| 2026-02-05 | 8-K | Officer / Director Changes | SEC |
| 2025-12-12 | 8-K | Shareholder Vote Results | SEC |
| 2025-09-30 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-05-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-03 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-04-02 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-12-10 | 8-K | Shareholder Vote Results | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-23 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-09-10 | 8-K | Other Events | SEC |
| 2024-08-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-12 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-07-02 | 8-K | Shareholder Vote Results | SEC |
| 2024-07-01 | 8-K | Other Events | SEC |
| 2024-06-11 | 8-K | Other Events | SEC |
| 2024-06-07 | 8-K | Listing Notice | SEC |
| 2024-05-22 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Auditor Change | SEC |
| 2024-05-06 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-04-23 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-04-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-06 | 8-K | Material Agreement, Unregistered Sales, Shareholder Vote Results | SEC |
| 2024-03-01 | 8-K | Listing Notice | SEC |
| 2024-02-16 | 8-K | Shareholder Vote Results | SEC |
| 2024-02-15 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-12 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-30 | 8-K | Officer / Director Changes | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.